Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
6,295 EUR | +4,31 % | +5,98 % | -70,42 % |
05/09 | Evotec y X-Chem colaborarán en el descubrimiento de fármacos en fase inicial | MT |
05/09 | Evotec SE y X-Chem Inc. colaboran para acelerar el descubrimiento de fármacos en fase inicial | CI |
Añadir a una lista 0 seleccionado | Ventas netas ($) (Y-1) | Margen neto (Y-1) | Margen Operativo (Y-1) | ROE (Y-1) | ROA (Y-1) | Apalancamiento (Dette/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
866 M | -10.74% | -3.41% | -5.46% | -2.80% | 0.33x | ||
7923,05 M | +9.74% | +13.98% | +6.52% | +3.82% | 0.46x | ||
14,98 mil M | +9.06% | +20.36% | +32.01% | +5.22% | 3.45x | ||
1828,29 M | -24.08% | -15.43% | - | -11.94% | 0.17x | ||
1638,81 M | +24.61% | +29.93% | +5.07% | +4.31% | 1.46x | ||
6848 M | -68.84% | -61.90% | -28.59% | -21.29% | 2.38x | ||
8120,18 M | +7.54% | +19.31% | +6.90% | +3.58% | 2x | ||
2327,5 M | +42.31% | +50.91% | +18.27% | +14.91% | -1.85x | ||
1159,06 M | +14.50% | +31.94% | +14.11% | +6.29% | 0.4x | ||
1885,84 M | +15.00% | +17.94% | +59.83% | +18.80% | -0.29x | ||
1965,31 M | +17.37% | +26.90% | +4.69% | +2.75% | 0.69x | ||
4129,41 M | +11.49% | +20.31% | +16.70% | +6.95% | 2.34x | ||
532 M | -40.26% | - | - | - | - | ||
11,58 M | -3,768.28% | -4,207.12% | -34.76% | -30.38% | 3.85x | ||
681 M | +19.38% | +22.41% | +9.00% | - | -1.79x | ||
788 M | -46.45% | -44.80% | -76.34% | -13.26% | 3.21x | ||
249 M | -203.30% | -194.99% | -157.13% | - | 0.99x | ||
1040,72 M | +27.44% | +35.35% | +9.95% | +7.09% | -1.51x | ||
1626,19 M | +13.88% | +14.92% | +13.86% | +6.82% | 1.36x | ||
Promedio | 3084,45 M | -207,87 % | -234,63 % | -6,20 % | +0,06 % | 0,98x | |
Media ponderada por Capi. | 5425,36 M | -91,95 % | -96,19 % | +4,16 % | +0,08 % | 1,26x |
- Bolsa de valores
- Acciones
- Acción EVT
- Sector Evotec SE
- Comparaciones Financieras
MarketScreener is also available in this country: United States.
Switch edition